Abstract

A role for the C-terminal domain (CTD) of murine leukemia virus (MuLV) Env protein in viral fusion was indicated by the potent inhibition of MuLV-induced fusion, but not receptor binding, by two rat monoclonal antibodies (MAbs) specific for epitopes in the CTD. Although these two MAbs, 35/56 and 83A25, have very different patterns of reactivity with viral isolates, determinants of both epitopes were mapped to the last C-terminal disulfide-bonded loop of SU (loop 10), and residues in this loop responsible for the different specificities of these MAbs were identified. Both MAbs reacted with a minor fraction of a truncated SU fragment terminating four residues after loop 10, indicating that while the deleted C-terminal residues were not part of these epitopes, they promoted their formation. Neither MAb recognized the loop 10 region expressed in isolated form, suggesting that these epitopes were not completely localized within loop 10 but required additional sequences located N terminal to the loop. Direct support for a role for loop 10 in fusion was provided by the demonstration that Env mutants containing an extra serine or threonine residue between the second and third positions of the loop were highly attenuated for infectivity and defective in fusion assays, despite wild-type levels of expression, processing, and receptor binding. Other mutations at positions 1 to 3 of loop 10 inhibited processing of the gPr80 precursor protein or led to increased shedding of SU, suggesting that loop 10 also affects Env folding and the stability of the interaction between SU and TM.

Highlights

  • Mechanisms by which the C-terminal domain (CTD) transduces the signal initiated by receptor binding, it has been suggested that isomerization of this disulfide bond may be an essential step in this process [36, 37]

  • A role for the C-terminal domain (CTD) of murine leukemia virus (MuLV) envelope glycoprotein complex (Env) protein in viral fusion was indicated by the potent inhibition of MuLV-induced fusion, but not receptor binding, by two rat monoclonal antibodies (MAbs) specific for epitopes in the CTD

  • Residues within loop 10 that determined the specificities of these MAbs were identified, a requirement was demonstrated for additional residues outside of loop 10 for reactivity with these MAbs, and mutations at specific sites in loop 10 were identified that differentially affected MuLV Env processing, virion association, and viral fusion

Read more

Summary

Introduction

Mechanisms by which the CTD transduces the signal initiated by receptor binding, it has been suggested that isomerization of this disulfide bond may be an essential step in this process [36, 37]. The two CTD-specific rat monoclonal antibodies (MAbs) used in that study, 35/56 [23] and 83A25 [11], have distinct strain specificities. Both of these MAbs neutralize MuLV infectivity by blocking a step prior to viral fusion but after receptor binding [7], and additional definition of these epitopes and characterization of the structure and function of this region were expected to provide new insight into the functions of the CTD during viral infection. Residues within loop 10 that determined the specificities of these MAbs were identified, a requirement was demonstrated for additional residues outside of loop 10 for reactivity with these MAbs, and mutations at specific sites in loop 10 were identified that differentially affected MuLV Env processing, virion association, and viral fusion

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.